DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers, $ API Reference Price

1 API Suppliers
1 Listed Suppliers
$ API Reference Price

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 11

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 401900-40-1, Gtx-007, (2s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, Gtx007, S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide, 7ut2hah49h

Molecular Formula

C₁₉H₁₈F₃N₃O₆

Molecular Weight

441.4 g/mol

InChI Key

YVXVTLGIDOACBJ-SFHVURJKSA-N

FDA UNII

7UT2HAH49H

Andarine is a non-steroidal selective androgen receptor modulator.

1 2D Structure

Andarine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

2.1.2 InChI

InChI=1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m0/s1

2.1.3 InChI Key

YVXVTLGIDOACBJ-SFHVURJKSA-N

2.1.4 Canonical SMILES

CC(=O)NC1=CC=C(C=C1)OCC(C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O

2.1.5 Isomeric SMILES

CC(=O)NC1=CC=C(C=C1)OC[C@@](C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O

2.2 Other Identifiers

2.2.1 UNII

7UT2HAH49H

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide

2. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide

3. S-4 Cpd

2.3.2 Depositor-Supplied Synonyms

1. 401900-40-1

2. Gtx-007

3. (2s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

4. Gtx007

5. S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide

6. 7ut2hah49h

7. Chembl125236

8. Propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)-, (2s)-

9. Andarine (gtx-007)

10. (2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide

11. (s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)propanamide

12. S-4

13. S-4 Cpd

14. Andarine;s4

15. Unii-7ut2hah49h

16. (s)-andarine

17. H_166_andarine_s4

18. Andarine - Gtx-007

19. Sarm S-4

20. Mls006010738

21. Gtx 007

22. Nonsteroidal Ar Ligand, S-6

23. Gtpl7849

24. Schembl2689756

25. Bdbm18665

26. Chebi:94760

27. Dtxsid40193187

28. Ex-a724

29. 3b68

30. Bcpp000400

31. Hms3654m08

32. Amy38109

33. Bcp01832

34. Zinc3991693

35. Mfcd09027386

36. S1140

37. Akos005145785

38. Akos015841082

39. Bmc185567 S-4

40. Bcp9000302

41. Ccg-264833

42. Cs-0160

43. Db07423

44. Ncgc00263150-01

45. Ncgc00263150-02

46. Ncgc00263150-04

47. Ac-26920

48. As-19581

49. Hy-12023

50. N-[4-nitro-3-(trifluoromethyl)phenyl]-(2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide

51. Smr004701697

52. Sw219160-1

53. 900n401

54. J-523346

55. Q4753617

56. Brd-k82164249-001-02-7

57. (2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

58. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide

59. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide, Analytical Standard

60. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide

61. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide

62. B68

63. N-[4-ntro-3-(trfluoromethyl)phenyl]-(2s)-3-[4-(acetylamno)phenoxy]-2-hydroxy-2-methylpropanamde

64. Propanamide, 3-?[4-?(acetylamino)?phenoxy]?-?2-?hydroxy-?2-?methyl-?n-?[4-?nitro-?3-?(trifluoromethyl)?phenyl]?-?, (2s)?-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₈F₃N₃O₆
Molecular Weight	441.4 g/mol
XLogP3	2.2
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	6
Exact Mass	441.11476979 g/mol
Monoisotopic Mass	441.11476979 g/mol
Topological Polar Surface Area	134 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	663
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1